Reports

Sale

Quantum Computing in Drug Discovery Market

Global Quantum Computing in Drug Discovery Market Size: By Product and Services: Target Identification / Validation, Hit Generation / Lead Identification, Lead Optimization; By Therapeutic Area: Cardiovascular Disorders, CNS Disorders, Dermatological Disorders, Others; Regional Analysis; Patent Analysis; Supplier Landscape; 2024-2032

Global Quantum Computing in Drug Discovery Market Outlook

The global quantum computing in drug discovery market market size attained a value of 609.1 in 2023. The market is expected to grow at a CAGR of 26.3% between 2024 and 2032, reaching almost 4,917.4 by 2032.

 

Quantum Computing in Drug Discovery: Introduction

Quantum computing is a contemporary approach that applies the principles of quantum physics to resolve a complex problem in a short span of time. Quantum theory explains the behaviour of energy at atomic and subatomic levels. It has found its pertinence in almost all domains, be it finance, security, military intelligence, machine learning, artificial intelligence, along with drug design and discovery.

 

The healthcare industry uses quantum computing for drug design, discovery, and advanced DNA research. Its ability to stimulate and analyze large and complex molecules in a shorter duration could prove to be a game changer for the future generations.

 

Global Quantum Computing in Drug Discovery Market Analysis

Early stages of drug development involve pattern recognition. Traditional methods rely on approximations and assumptions of molecular behavior. This is not only time consuming but also allows a scope of error. When compared to conventional computers, quantum computers stimulate and analyze the behavior of large molecules faster. Most of the quantum computing systems use atoms or ions, but now “qubits” enable the system to look at all possible outcomes of an issue and analyze them simultaneously. Additionally, Algoritmiq, a scaleup, raised USD 15 million to develop quantum algorithms that address the most complex issues in pharmaceuticals revolving around time and cost in drug discovery and development.

 

Creating a library of small molecules that may interact with the target protein is a crucial step of drug discovery. In May 2024, POLARISqb launched QuADD (Quantum-Aided Drug Design), a subscription-based SaaS (software as a service) platform that optimizes the library of best candidate molecules to be used as drug targets.

 

Traditionally, scientists would rely on wet-lab testing that would take years to provide results and was also limited to certain chemicals, but this process can now accelerate using a quantum annealing computer. With an emerging startup culture, we can expect some hefty investments in similar technologies that may contribute to the steadily rising quantum computing in drug discovery market value.

 

Quantum computing machine learning can also improve the already existing artificial intelligence models, with its ability to find patterns in medical imaging data and electronic health logs. This can lead to better accuracy and processing power of models, like BioGPT, by helping with specific statistical calculations. Such developments indicate that quantum computing in drug discovery market demand is going to expand in the future.

 

Global Quantum Computing in Drug Discovery Market Segmentation

Market Breakup by Product and Services

  • Target Identification / Validation
  • Hit Generation / Lead Identification 
  • Lead Optimization

 

Market Breakup by Therapeutic Area

  • Cardiovascular Disorders
  • CNS Disorders
  • Dermatological Disorders
  • Endocrine Disorders
  • Gastrointestinal Disorders
  • Immunological Disorders
  • Infectious Diseases
  • Musculoskeletal Disorders
  • Oncological Disorders
  • Respiratory Disorders
  • Others

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Quantum Computing in Drug Discovery Market Overview

Drug development is a time consuming and complex process that can cost up to billions. With the incidence of chronic diseases, post COVID-19 complications and the increasing geriatric population, the demand for drugs has increased. Hence, researchers and scientists have turned to quantum computing to offer accurate and rapid drug discoveries. When combined with other cutting-edge technologies like artificial intelligence, machine learning and cloud computing, quantum computing in drug discovery market growth is certain in the coming years.

 

Owing to the existence of a robust healthcare and technology driven infrastructure, North America is anticipated to aid the quantum computing in drug discovery market share in the forecast period. The presence of key healthcare players that commit to driving the market towards better technology and solutions will also aid the expansion.

 

Global Quantum Computing in Drug Discovery Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Accenture
  • Amazon Web Service
  • Atos
  • Fujitsu
  • Huwaei
  • IBM
  • Microsoft
  • Xanadu
  • XtalPi

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product and Services
  • Therapeutic Area
  • Region
Breakup by Product and Services
  • Target Identification / Validation
  • Hit Generation / Lead Identification
  • Lead Optimization
Breakup by Therapeutic Area
  • Cardiovascular Disorders
  • CNS Disorders
  • Dermatological Disorders
  • Endocrine Disorders
  • Gastrointestinal Disorders
  • Immunological Disorders
  • Infectious Diseases
  • Musculoskeletal Disorders
  • Oncological Disorders
  • Respiratory Disorders
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Accenture
  • Amazon Web Service
  • Atos
  • Fujitsu
  • Huwaei
  • IBM
  • Microsoft
  • Xanadu
  • XtalPi

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Quantum Computing in Drug Discovery Market Overview 

    3.1    Global Quantum Computing in Drug Discovery Market Historical Value (2017-2023) 
    3.2    Global Quantum Computing in Drug Discovery Market Forecast Value (2024-2032)
4    Global Quantum Computing in Drug Discovery Market Landscape
    4.1    Global Quantum Computing in Drug Discovery: Developers Landscape
    4.1.1    Analysis by Year of Establishment
    4.1.2    Analysis by Company Size
    4.1.3    Analysis by Region
    4.2    Global Quantum Computing in Drug Discovery: Product Landscape
    4.2.1    Analysis by Type
    4.2.2    Analysis by Technology
    4.2.3    Analysis by Applications
5    Global Quantum Computing in Drug Discovery Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Quantum Computing in Drug Discovery Market Segmentation
    6.1    Global Quantum Computing in Drug Discovery Market by Product and Services
        6.1.1    Market Overview
        6.1.2    Target Identification / Validation
        6.1.3    Hit Generation / Lead Identification
        6.1.4    Lead Optimization
    6.2    Global Quantum Computing in Drug Discovery Market by Therapeutic Area
        6.2.1    Market Overview
        6.2.2    Cardiovascular Disorders
        6.2.3    CNS Disorders
        6.2.4    Dermatological Disorders
        6.2.5    Endocrine Disorders
        6.2.6    Gastrointestinal Disorders
        6.2.7    Immunological Disorders
        6.2.8    Infectious Diseases
        6.2.9    Musculoskeletal Disorders
        6.2.10    Oncological Disorders
        6.2.11    Respiratory Disorders
        6.2.12    Others
    6.3    Global Quantum Computing in Drug Discovery Market by Region
        6.3.1    Market Overview
        6.3.2    North America
        6.3.3    Europe 
        6.3.4    Asia Pacific
        6.3.5    Latin America
        6.3.6    Middle East and Africa
7    North America Quantum Computing in Drug Discovery Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Quantum Computing in Drug Discovery Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Quantum Computing in Drug Discovery Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Quantum Computing in Drug Discovery Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Quantum Computing in Drug Discovery Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Funding and Investment Analysis
    15.1    Analysis by Funding Instances
    15.2    Analysis by Type of Funding
    15.3    Analysis by Funding Amount
    15.4    Analysis by Leading Players
    15.5    Analysis by Leading Investors
    15.6    Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership
    16.3    Analysis by Leading Players
    16.4    Analysis by Geography
17    Supplier Landscape
    17.1    Accenture
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications 
    17.2    Amazon Web Service
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Atos
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Fujitsu
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Huwaei
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    IBM
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Microsoft
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Xanadu
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    XtalPi
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
18    Key Opinion Leaders (KOL) Insights (Additional Insight)
19    Company Competitiveness Analysis (Additional Insight)

    19.1    Very Small Companies
    19.2    Small Companies
    19.3    Mid-Sized Companies
    19.4    Large Companies
    19.5    Very Large Companies
20    Payment Methods (Additional Insight)
    20.1    Government Funded
    20.2    Private Insurance
    20.3    Out-of-Pocket
    

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 609.1 million in 2023, driven by the emphasis on accurate and streamlined drug production and discoveries for the patients.

The market is anticipated to grow at a CAGR of 26.3% during the forecast period of 2024-2032, likely to reach a market value of USD by 4,917.4 million 2032.

With the rise in chronic diseases, quality drug production has emerged as an essential field of innovation. As a result, scientists have turned towards latest technologies like quantum computing to save the time and cost of drug discoveries. This has fuelled the market growth.

The current market trend involves the prevalence of both software and hardware to facilitate effective drug production. There have been increasing investments in startups to promote new inventions.

It can be used in cardiovascular, CNS, dermatological, endocrine, gastrointestinal, immunological, musculoskeletal, infectious, oncological, and respiratory disorders, among others.

Quantum computing can help in the target identification or validation of a drug, along with hit generation, lead identification and lead optimization.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Key players involved in the market are Accenture, Amazon Web Service, Atos, Fujitsu, Huwaei, IBM, Microsoft, Xanadu, and XtalPi.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER